Skip to main
MRUS
MRUS logo

Merus (MRUS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Merus (MRUS) Stock

About Merus (MRUS)

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
Market cap$3.97B
Yesterday's volume589.92K
Revenue (TTM)$54.73M
Avg. daily volume1.2M
EBITDA (TTM)-$298.55M
Open$52.53
Price / earnings ratio-12.94x
Yesterday's range$52.53 - $54.18
Debt / equity1.65x
52 week range$33.19 - $62.98
5 year debt / equity2.43x
Beta (LTM)0.97x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio5.86x
Ex-dividend date
Next earningsJul 31, 2025
Dividend payable date

Merus Stock Rating

What analysts recommend for MRUS stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 63%
Buy 32%
Hold 5%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for Merus stock is $3.98B

The current P/E ratio for Merus stock is -12.94

The 52-week high for Merus stock is $62.98. The current Merus stock price $undefined is 100.00% below its 52-week high

The 52-week low for Merus stock is $33.19. The current Merus stock price $undefined has increased 100.00% from its 52-week low

No, the Merus stock does not pay dividends to its shareholders

The target price for Merus stock is $69.84 based on the average of what a group of analyst think Merus stock could be worth at a future date. This is not a prediction by Public.com

How to buy Merus stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Merus stock

    Navigate to the Explore page. Then, type Merus into the search bar. When you see Merus stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Merus stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Merus Stock Earnings

The value each MRUS share was expected to gain vs. the value that each MRUS share actually gained.

Merus (MRUS) reported Q1 2025 earnings per share (EPS) of -$1.40, missing estimates of -$1.05 by 33.33%. In the same quarter last year, Merus's earnings per share (EPS) was -$0.59. Merus is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of -$1.15.

Buy Merus (MRUS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.